Mitsuhisa Matsuo

Title: Mitsuhisa Matsuo: Innovator in Cancer Therapy

Introduction

Mitsuhisa Matsuo is a notable inventor based in Chiba, Japan. He has made significant contributions to the field of cancer therapy, particularly in determining sensitivity to anti-cancer agents. With a total of two patents to his name, Matsuo's work is paving the way for advancements in personalized medicine.

Latest Patents

Matsuo's latest patents include a method for determining sensitivity to fluorouracil in subjects with colorectal cancer. This innovative method provides a marker that can assess whether a patient has a therapeutic response to the anti-cancer agent. His second patent focuses on a marker for determining sensitivity to anti-cancer agents, which can also indicate a patient's therapeutic response. The markers identified in his patents include various substances related to amino acid and nucleic acid metabolism, as well as compounds involved in several metabolic pathways.

Career Highlights

Throughout his career, Matsuo has worked with prestigious institutions, including Keio University and Yakult Honsha Co., Ltd. His research has been instrumental in developing new cancer therapies that utilize the markers he has identified.

Collaborations

Matsuo has collaborated with notable colleagues such as Yusuke Tanigawara and Akito Nishimuta. Their combined expertise has contributed to the advancement of cancer treatment methodologies.

Conclusion

Mitsuhisa Matsuo's innovative work in cancer therapy exemplifies the impact of research and invention in the medical field. His patents are a testament to his dedication to improving patient outcomes through personalized medicine.